| Literature DB >> 32818059 |
Christopher Clifford1,2, Dimitris Challoumas3, Lorna Paul4, Grant Syme5, Neal L Millar2.
Abstract
OBJECTIVE: To systematically review and critically appraise the literature on the effectiveness of isometric exercise in comparison with other treatment strategies or no treatment in tendinopathy.Entities:
Keywords: physiotherapy; tendinopathy; tendon
Year: 2020 PMID: 32818059 PMCID: PMC7406028 DOI: 10.1136/bmjsem-2020-000760
Source DB: PubMed Journal: BMJ Open Sport Exerc Med ISSN: 2055-7647
Figure 1PRISMA flow diagram of included studies. CINAHL, Cumulative Index to Nursing and Allied Health Literature; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
Methodological characteristics, inclusion and exclusion criteria, and follow-up completion rates of the included studies
| Author | Study type | Randomisation method | Blinding method | Allocation concealment | Statistical power calculation | Baseline comparison | Inclusion criteria | Exclusion criteria | Follow-up completion (%) |
| Gatz | RCT. | Numbered envelopes. | None. | Sealed envelopes. | Yes; sample size adequate for 82% power. | No difference. | ≥18 years, insertional or midportion Achilles tendinopathy diagnosed with history and examination (provoked pain by palpation), physical ability to perform exercises. | Pregnancy, very high (>35) or very low (<17) BMI, previous rupture or operation in area of symptoms, injections in last 6 months. | 71 |
| Clifford | Pilot RCT. | Random selection of sealed, opaque envelopes from box. | None. | Sealed, opaque envelopes. | No. | No difference. | ≥18 years, lateral hip pain >3 months, pain over greater trochanter and one of the following: (1) single leg stand 30 s, (2) FADER, (3) FADER and resisted IR, (4) FABER, and (5) resisted hip abduction at end-range adduction. | Physiotherapy in previous 6 months, corticosteroid injection in previous 3 months, hip or lumbar spine surgery in previous 12 months, moderate to severe hip osteoarthritis. | 77 |
| Holden | RCT single-blind (cross-over). | Computer-generated allocation sequence. | Researcher blinded to sequence allocation. | Sealed, opaque envelopes, sequence randomised by independent researcher. | Yes; sample size adequate for 90% power. | No difference. | 18–40 years of age, patellar tendinopathy clinically and radiologically. | Concurrent knee pathologies, previous knee surgery, corticosteroid injection in last 6 months. | 95 |
| Vuvan | RCT. | Computer-generated. | Not stated. | Sealed, opaque envelopes. | Yes; sample size adequate for 80% power. | No difference. | 18–70 years, symptoms for >6 weeks, NPRS ≥2/10, at least two of the following: (1) gripping, (2) palpation of lateral epicondyle, (3) stretching of forearm muscles, (4) resisted wrist, second or third finger extension, and (5) reduced pain-free grip strength. | Other sources of elbow pain, major neurological, inflammatory or systemic conditions, treatment by a healthcare practitioner within the previous 3 months, injections within the preceding 6 months, or major trauma, fracture or surgery in the last year. | 98 |
| Dupuis | RCT single-blind. | Random number generator and block design. | Blinded outcome assessment (participants asked not to discuss their treatment with assessor). | Sealed, opaque envelopes. | Yes; sample size adequate for 80% power. | Cryotherapy group older. | 16–65 years, symptoms <6 weeks, painful arc of movement, positive Neer’s or Kennedy-Hawkins and pain on resisted isometric external rotation, abduction, or positive Jobe’s all present. | Upper limb fracture, previous neck or shoulder surgery, cervical spine involvement, frozen shoulder, sign of full cuff tear, rheumatological, inflammatory or neurological disease. | 77 |
| Parle | RCT single-blind pilot. | Random number generator. | Chief investigator and sonographer blinded to groups. | Sealed, opaque envelopes. | No. | Not done. | Unilateral shoulder pain <12 weeks, symptoms aggravated with active or resisted movement, unaccustomed increase in shoulder activity preceding symptoms, evidence of bursitis or tendinosis on ultrasound. | Dominant biceps pain, frozen shoulder, full thickness or large partial thickness tears, and traumatic onset of pain. | 100 |
| Rio | RCT single-blind. | Random number generator function of Microsoft Excel. | Not stated. | Unmarked, opaque envelopes. | No. | No difference. | Elite and subelite volleyball and basketball athletes over 16 years of age. | Existence of other knee pathology, previous patellar tendon rupture, previous patellar tendon surgery, inflammatory disorders, metabolic bone diseases and type II diabetes, use of fluoroquinolones or corticosteroids in the last 12 months, known familial hypercholesterolaemia and fibromyalgia. | 62 |
| Diagnosis made clinically and radiologically. | |||||||||
| Stasinopoulos and Stasinopoulos | RCT single-blind. | ‘By drawing lots’. | Outcome assessor blinded to groups. | Not stated. | No. | No difference. | Amateur tennis athletes. | Dysfunction in the shoulder, neck (radiculopathy) and/or thoracic region, local or generalised arthritis, neurological deficit, radial nerve entrapment, limitations in arm functions, the affected elbow had been operated on, had received any conservative treatment in the 4 weeks before entering the study. | 100 |
| Clinical diagnosis of lateral elbow tendinopathy for at least 4 weeks. | |||||||||
| van Ark | RCT single-blind. | Random number generator function of Microsoft Excel. | Not stated. | Unmarked, opaque envelopes. | No. | No difference. | Elite and subelite volleyball and basketball athletes over 16 years of age. | Existence of other knee pathology, previous patellar tendon rupture, previous patellar tendon surgery, inflammatory disorders, metabolic bone diseases and type II diabetes, use of fluoroquinolones or corticosteroids in the last 12 months, known familial hypercholesterolaemia and fibromyalgia. | 62 |
| Diagnosis made clinically and radiologically. | |||||||||
| Rio | RCT single-blind (cross- over). | Participants chose an envelope for order of intervention. | Not stated. | Unmarked, opaque envelopes. | No. | No difference. | Volleyball players who were taking no medications. | – | 100 |
BMI, body mass index; FABER, flexion abduction external rotation; FADER, flexion adduction external rotation; IR, internal rotation; NPRS, Numerical Pain Rating Scale; RCT, randomised controlled trial.
Samples, characteristics of interventions and outcome measures of the included studies
| Author | Tendon affected | Sample, mean/median age (range); % F | Symptom duration | Interventions | Treatment duration (follow-up) | Adherence to treatment | Outcome measures |
| Gatz | Achilles. | n=42, mean 49.5 years (21–73 years); 36%. | 2–100 months (mean 27.5 months). | Isotonic (eccentric) exercise (n=20). Isotonic (eccentric) exercise + isometric exercise (n=22). | 3 months | 100% in first month and around 50% thereafter. | VISA-A (pain, function). AOFAS (pain, function). Likert scale (clinical improvement with treatment). Roles and Maudsley score (clinical improvement with treatment). Tissue elasticity (shear wave elastography). |
| Clifford | Gluteal. | n=30, mean 59.3 years (24–86 years); 90%. | Mean 23 months. | Isometric exercise (n=15). Isotonic exercise (n=15). | 12 weeks | 70% of isometric group and 58% of isotonic group completed 80% of treatment sessions. | Tendon-specific: VISA-G (pain, function). NPRS 0–10 for pain. EQ-5D-5L (QoL). IPAQ-SF. GROC. PCS. HOOS. |
| Holden | Patellar. | n=21, mean 26.5 years (18–40 years); 41%. | 10–84 months (mean 24 months). | Isometric exercise (n=21). Dynamic (isotonic) exercise (n=21). | Single session of each intervention. | N/A. | Pain intensity during SLDS (NRS 0–10). Pressure pain thresholds. Patellar tendon thickness (USS). |
| Vuvan | Wrist extensors. | n=40, mean 48.5 years (?– ? years); 28%. | 2–8 months (mean 4 months). | Wait and see (n=19). Isometric exercise (n=21). | 8 weeks | 87%. | GROC. Tendon-specific: PRTEE (pain, disability). VAS 0–10 for pain. Pain-free grip strength (function). Thermal and pressure pain threshold (nervous system sensitisation). |
| Dupuis | Rotator cuff. | n=43, mean 38.3 years (18–65 years); 44%. | <6 weeks. | Weeks 0–2: Isometric exercise (n=20). Ice therapy (n=23). | 6 weeks | Weeks 0–2: exercise group 76% and cryotherapy group 80%. | USS to measure acromiohumeral distance. Strength (maximum force in shoulder abduction and external rotation). ROM. DASH (functional disability). Tendon-specific: WORC (QoL). BPI (pain 0–10). |
| Parle | Rotator cuff. | n=20, mean 50 years (20–67 years); 65%. | <12 weeks. | Ice therapy (n=6). Isometric exercise (n=7). Ice therapy plus isometric exercise (n=7). | 1 week | Unclear. | VAS 0–10 for pain. DASH (functional disability). Strength (maximum force in shoulder flexion). Structural integrity (USS). |
| Rio | Patellar. | n=29, mean 23 years (16–32 years); 7%. | 1–120 months (mean 35.8 months). | Isometric exercise (n=13). Isotonic exercise (n=16). | 4 weeks | Unclear. | Pain during the SLDS (NRS 0–10) preintervention and postintervention. Tendon-specific: VISA-P (pain, function). |
| Stasinopoulos and Stasinopoulos | Wrist extensors. | n=34, mean 43 years; 56%. | >4 weeks (mean 6 months). | Eccentric exercise (n=11). Eccentric-concentric exercise (n=12). Eccentric-concentric exercise + isometric exercise (n=11). | 4 weeks | Unclear. | VAS 0–10 for pain. Pain-free grip strength (function). VAS 0–10 for function. |
| van Ark | Patellar. | n=29, mean 23 years (16–32 years); 7%. | 1–120 months (mean 35.8 months). | Isometric exercise (n=13). Isotonic exercise (n=16). | 4 weeks | Unclear. | Pain during the SLDS (0–10). Tendon-specific: VISA-P (pain, function). |
| Rio | Patellar. | n=6, median 27 years (18–40 years); 0%. | Not stated. | Isometric exercise (n=6). Isotonic exercise (n=6). | Single session of each intervention (0–45 min). | N/A. | Pain during the SLDS (NRS 0–10). Strength (quadriceps MVIC). Measures of corticospinal excitability and inhibition. |
The clinical parameters assessed by each questionnaire in the outcome measures are stated in brackets.
AOFAS, American Orthopaedic Foot and Ankle Score; BPI, Brief Pain Inventory; DASH, Disabilities of the Arm, Shoulder and Hand; EQ-5D-5L, EuroQoL 5 Dimensions 5 Level Index; GROC, Global Rating of Change; HOOS, Hip Disability and Osteoarthritis Outcome Score; IPAQ-SF, International Physical Activity Questionnaire-Short Form; MVIC, maximum voluntary isometric contraction; N/A, not applicable; NPRS, Numeric Pain Rating Scale; NRS, Numeric Rating Scale; PCS, Pain Catastrophising Scale; PRTEE, Patient-Rated Tennis Elbow Evaluation; QoL, quality of life; ROM, range of movement; SLDS, single leg decline squat; USS, ultrasound scan; VAS, Visual Analogue Scale; VISA-A, Victorian Institute of Sport Assessment-Achilles tendon; VISA-G, Victorian Institute of Sport Assessment-gluteal tendons; VISA-P, Victorian Institute of Sport Assessment-patellar tendon;; WORC, Western Ontario Rotator Cuff Index.
Quality assessment of included studies (internal validity, external validity, precision and overall quality)
| First author (year) | Internal validity | External validity | Precision | Overall quality | ||||||
| Selection bias | Performance bias | Detection bias | Attrition bias | Reporting bias | Other | |||||
| Random sequence generation | Allocation concealment | Blinding of patients and staff | Blinding of outcome measures | Completeness of outcome data | Selective reporting | |||||
| Gatz (2020) | Low | Low | High | High | Low | High | Low | Low | Low | Poor |
| Clifford (2019) | Low | Low | High | High | Low | High | High | Low | High | Poor |
| Holden (2020) | Low | Low | Low | High | Low | Low | Low | Low | Low | Good |
| Vuvan (2020) | Low | Low | High | Low | Low | Low | Low | Low | Low | Good |
| Dupuis (2018) | Low | Low | Low | Low | Low | Low | High | Low | Low | Good |
| Parle (2017) | Low | Low | High | Low | Low | Low | High | Low | High | Poor |
| Rio (2017) | Low | Low | High | High | High | Low | High | High | High | Poor |
| Stasinopoulos (2017) | Low | ? | High | Low | Low | Low | ? | High | High | Poor |
| van Ark (2015) | Low | Low | High | High | High | Low | High | High | High | Poor |
| Rio (2015) | Low | Low | High | ? | Low | Low | High | High | High | Poor |
?: unclear risk of bias.
Figure 2Forest plot for the comparison between isometric and isotonic exercise with regard to immediate postintervention improvement in reported pain. IV, intervention.
Findings of studies that assessed outcomes immediately after exercise (45 min postintervention)
| Treatment modes | Tendon affected | First author (year) | Pain | Functional disability | ROM | Strength | QoL | Structural integrity | Cortical inhibition |
| Isometric exercise versus isotonic exercise | Rio | ↓ (ΝRS) | – | – | ↑ | – | – | ↑ | |
| Patellar | Rio | ↓ (ΝRS) | – | – | – | – | – | – | |
| Holden (2020) | ↔ (NRS) | – | – | – | – | ↔ | – | ||
| Overall isometric versus isotonic exercise (evidence level) | ↔ (3) | – | – | ↑ (3) | – | ↔ (3) | ↑ (3) | ||
↓: lower at statistical significance*; ↑: higher at statistical significance*; ↔: no statistically significant difference.
*With the first versus the second intervention.
NRS, Numeric Rating Scale; QoL, quality of life; ROM, range of movement.
Findings of studies reporting short-term outcomes (up to 12 weeks of follow-up)
| Acute/chronic tendinopathy | Treatment modes | Tendon affected | First author (year) | Pain | Functional disability | ROM | Strength | Satisfaction | Structural integrity | QoL |
| Acute | Combined isometric exercise/ice therapy versus ice therapy | Rotator cuff | Parle (2017) | ↔ (VAS) | ↔ (DASH) | – | ↔ | – | ↔ | – |
| Isometric exercise versus ice | Rotator cuff | Parle (2017) | ↔ (VAS) | ↔ (DASH) | – | ↔ | – | ↔ | – | |
| Dupuis (2018) | ↔ (BPI) | ↔ (DASH) | ↔ | ↔ | – | ↔ (WORC) | ||||
| Overall isometric exercise versus ice (evidence level) | ↔ (3) | ↔ (3) | ↔ (3) | ↔ (3) | ↔ (3) | ↔ (3) | ↔ (3) | |||
| Chronic | Isometric versus isotonic exercise | Patellar | van Ark (2016) | ↔ (NRS) | ↔ (VISA-P) | – | – | ↔ (GROC) | – | – |
| Greater trochanteric pain syndrome | Clifford (2019) | ↔ (NRS) | ↔ (VISA-G) | – | – | ↔ (GROC) | – | ↔ (EQ-5D-5L) | ||
| Overall isometric versus isotonic exercise (evidence level) | – | – | – | |||||||
| Chronic | Combined isometric/isotonic exercise versus isotonic exercise | Wrist extensors | Stasinopoulos (2017) | ↓ (VAS) | ↓ (pain-free grip strength) | – | – | – | – | – |
| Achilles | Gatz (2020) | – | ↔ (VISA-A, AOFAS) | – | – | – | – | – | ||
| Overall combined isometric/isotonic exercise versus isotonic exercise (evidence level) | – | – | – | – | – | |||||
| Isometric exercise versus no treatment | Wrist extensors | Vuvan (2020) | – | ↔ (pain-free grip strength) | – | – | ↔ (GROC) | – | – | |
↓: lower at statistical significance*; ↑: higher at statistical significance*; ↔: no statistically significant difference.
*With the first versus the second intervention.
AOFAS, American Orthopaedic Foot and Ankle Score; BPI, Brief Pain Inventory; DASH, Disabilities of the Arm, Shoulder and Hand; EQ-5D-5L, EuroQoL 5 Dimensions 5 Level Index; GROC, Global Rating of Change; NRS, Numeric Rating Scale; PRTEE, Patient-Rated Tennis Elbow Evaluation; QoL, quality of life; ROM, range of movement; VAS, Visual Analogue Scale; VISA-A, Victorian Institute of Sport Assessment-Achilles tendon; VISA-G, Victorian Institute of Sport Assessment-gluteal tendons; VISA-P, Victorian Institute of Sport Assessment-patellar tendon; WORC, Western Ontario Rotator Cuff Index.
Mean values of pain scales and treatment effect for pain of isometric exercise versus control (isotonic exercise): studies assessing outcomes immediately after exercise (45 min postintervention)
| Acute/chronic | Treatment modes | Tendon affected | First author (year) | Pain scale | Scale range | Isometric group pain score | Control group pain score | Mean treatment effect for pain (95% CI) | P value <0.05 | ||
| Baseline (1) | Postintervention (2) | Baseline (3) | Postintervention (4) | ||||||||
| Chronic | Isometric versus isotonic exercise | Patellar | Rio (2015) | NRS (during SLDS) | 0–10 | 7 | 0.2 | 6.3 | 3.8 | −4.3 (−1.2 to −7.4) | Yes |
| Rio (2017) | NRS (during SLDS) | 0–10 | 5 | 3.2 | 5 | 4.1 | −0.9 (−1.1 to −0.7) | Yes | |||
| Holden (2020) | NRS (during SLDS) | 0–10 | 5 | 4.2 | 4.3 | 3.2 | +0.3 (1.3 to −0.7) | No | |||
NRS, Numeric Rating Scale; SLDS, single leg decline squat.
Mean values of pain scales and treatment effect for pain of isometric exercise versus control (isotonic exercise, ice or no treatment): studies assessing outcomes in the short-term (up to 12 weeks)
| Acute/chronic | Treatment modes | Tendon affected | First author (year) | Pain scale | Scale range | Isometric group pain score | Control group pain score | Mean treatment effect for pain (2–1) – (4–3) (95% CI) | P value <0.05 | ||
| Baseline (1) | Longest follow-up (2) | Baseline (3) | Longest follow-up (4) | ||||||||
| Acute | Combined isometric exercise/ice therapy versus ice therapy | Rotator cuff | Parle (2017) | VAS | 0–10 | 4.8 | 3.7 | 5.5 | 4.5 | −0.1 (N/A) | No |
| Isometric exercise versus ice | Rotator cuff | Parle (2017) | VAS | 0–10 | 6.3 | 4.5 | 5.5 | 4.5 | −0.8 (N/A) | No | |
| Dupuis (2018) | BPI | 0–10 | 3.2 | 1.6 | 2.7 | 1.2 | −0.1 (−1.2 to 1) | No | |||
| Chronic | Isometric versus isotonic exercise | Patellar | van Ark (2016) | NRS | 0–10 | 6.3 | 4 | 5.5 | 2 | −0.5* (−2.6 to 1.6) | No |
| Greater trochanteric pain syndrome | Clifford (2019) | NRS | 0–10 | 5.9 | 3.9 | 5.9 | 3.2 | +0.7 (−0.7 to 1.7) | No | ||
| Chronic | Combined isometric/isotonic exercise versus isotonic exercise | Wrist extensors | Stasinopoulos (2017) | VAS | 0–10 | 6.9 | 1.6 | 6.9 | 2.9 | −1.3 (−0.8 to −1.9) | Yes |
CIs have been calculated (see Statistical analysis section).
*Values at baseline and follow-up are median and not mean; therefore, the 0.5 value (also median) reported by the authors cannot be obtained from the calculation.
BPI, Brief Pain Inventory; N/A, not applicable; NRS, Numeric Rating Scale; VAS, Visual Analogue Scale.